title: Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions.
abstract: Peritoneal dialysis (PD) is now an established and successful alternative to hemodialysis. Multiple studies have confirmed its equivalent dialysis adequacy, mortality and fluid balance status, at least for the first 4-5 years. Peritoneal membrane failure is now one of the leading cause of technique failure. This review describes the role of glucose, glucose degradation product, pH, lactate, advanced glycosylation end product (AGE) in causing this membrane damage, and gives insight how the use of newer peritoneal dialysis fluids (PDFs) containing icodextrin, amino acids and bicarbonate buffer can prevent peritoneal membrane damage.
authors.affiliation: Department of Nephrology, Toronto Western Hospital, University Health Network, University of Toronto, Toronto m5b2e8, Ontario, Canada. mufazzal2002@yahoo.co.in
authors.forename: Mufazzal
authors.initials: M
authors.lastname: Ahmad
authors.forename: Hemal
authors.initials: H
authors.lastname: Shah
authors.forename: Theodori
authors.initials: T
authors.lastname: Pliakogiannis
authors.forename: Dimitrios G
authors.initials: DG
authors.lastname: Oreopoulos
mesh_terms: D015314:Dialysis Solutions / Q000378:metabolism*; D004848:Epithelium; D005936:Glucans / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D017127:Glycation End Products, Advanced / Q000009:adverse effects; D006801:Humans; D000077607:Icodextrin; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010537:Peritoneum / Q000098:blood supply / Q000473:pathology*
chemical_list: D015314:Dialysis Solutions; D005936:Glucans; D017127:Glycation End Products, Advanced; D000077607:Icodextrin; D005947:Glucose